Sight
Biotechnology ResearchIsrael51-200 Employees
By analyzing exclusive proprietary multidimensional live-single-cell functional imaging data, digitally generated from millions of live immune cells with our de-risked core technology platform, we discover, develop and deploy multi-function, explainable, and biologically backed imaging-based digital signatures. With unprecedented clinical accuracy, we are pioneering a new generation of immune signatures, to predict, detect, guide therapies, and profile the immune system state across health and disease, aiming to solve the greatest immune-related clinical challenges, one immune signature at a time.